Cis-(+/-)-2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one
Cis-(+/-)-2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one
SMILES |
COC1=CC(=C(C=C1)F)CCCC2CCC(O2)CCNCCCCCN3C(=O)C4CC=CCC4C(=N3)C5=CC(=C(C=C5)OC)OC |
InChIKey |
ILYANWOXFYOOPX-UHFFFAOYSA-N |
Chemical Properties
Hydrogen bond acceptors |
7 |
Hydrogen bond donors |
1 |
Rotatable bonds |
17 |
Molecular weight (Da) |
635.4 |
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Cis-(+/-)-2-{5-[3-(5-Fluoro-2-methoxy-phenyl)-propyl]-tetrahydro-furan-2-yl}-ethylamine)-pentyl-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one
Drug properties
Molecular type |
Small molecule |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.